Our findings revealed that silibinin treatment resulted in the accumulation of cleaved caspase 8 in a dose‐dependent manner, while it had no effect on cleaved caspase 9 levels in both HCC‐LM3 and MHCC97‐H cell lines (Figure 6A). Here, CASP9 is linked to hepatocellular carcinoma.